Researchers of the Human Brain Project have developed a new methodology to calculate the delay of signal propagations in brains of patients suffering from multiple sclerosis, a chronic inflammatory disease that affects more than 2 million people worldwide.

Aimed at researchers eager to exploit their research results, the Startups & Fundraising report introduces the possibilities of the entrepreneurship world.

This report, elaborated by the HBP Innovation team, originates from the SGA3 phase of the Human Brain Project, as a business intelligence work aiming to support decision-making processes on the exploitation of research results. In particular, the report is targeting specialized groups in the neurological, neurocomputing and neurotechnological areas, to facilitate a more profound understanding of brain diseases and the reaction of human brain in front of different types of stimulus.

“Target” and “distractor” neurons may shape how the brain handles distracting information

On 12 October, HBP Scientific Director Katrin Amunts and Tommaso Calarco, chair of the Quantum Community Network of the Quantum Flagship, presented two special pieces from Forschungszentrum Jülich to the European Commission in Brussels: an enlarged image of human brain fibres and a true-to-scale replica of the quantum computer "OpenSuperQ".

The cerebral cortex organizes itself in specific neuronal assemblies when consciously perceiving sounds, generating “creative” patterns of activity.

Light-Sheet Fluorescence Microscopy (LSFM) of cleared brain samples offers the unique opportunity of exploring brain complexity on large scales yet at cellular resolution. The European Laboratory for Non-Linear Spectroscopy (LENS) has gathered long-standing experience in the whole LSFM pipeline, comprising sample preparation (clearing and staining), the actual imaging using custom-designed optical setups, and image post-processing (volumetric stitching, compression, feature segmentation). The LENS facility hub offers access to two microscopy setups capable of high-speed and high-resolution imaging with simultaneous two-color acquisition. One system can accommodate large bulky samples such as a whole mouse brain, while the other microscope is designed for …

A study by Human Brain Project (HBP) researchers identifies a new marker for predicting the clinical outcome of patients of Amyotrophic Lateral Sclerosis (ALS) through magnetoencephalography. This marker can be measured in the brain during its resting state and highlights the importance of brain flexibility for ALS patients. The study, published in Neurology, has been led by the Institut de Neurosciences des Systèmes in Marseille, in collaboration with Consiglio Nazionale delle Ricerche, Parthenope University of Naples and Institute of Diagnosis and Care Hermitage Capodimonte in Naples, and the Monash University in Melbourne.

A new field of science has been emerging at the intersection of neuroscience and high-performance computing - this is the takeaway from the 2022 BrainComp conference, which took place in Cetraro, Italy from the 19th to the 22nd of September. The meeting, which featured international experts in brain mapping, machine learning, simulation, research infrastructures, neuro-derived hardware, neuroethics and more, strengthened the current collaborations in this emerging field and forged new ones.

The ethical and social implications of using artificial intelligence in life science – or society – have become the main hurdle for implementation. The debate has intensified in recent years, bringing a long list of solutions in the form of approaches, tools and initiatives. One of the more prominent examples of this is the European Union’s Assessment list for trustworthy AI, or ALTAI, developed by the EU’s high-level expert group on artificial intelligence. How does it work? A recent paper published in AI and Ethics presents a first empirical test in a live setting: Looking at neuro-informatics in the Human …